Subjects
There were I7 men and 3 women whose ages ranged from 43 to 82 (mean age 59-2, SD II-4). A diagnosis of myocardial infarction was made when a typical history was accompanied by a rise in the serum aspartate aminotransferase and diagnostic changes in the electrocardiogram. These criteria were met by i8 out of 20 patients. The remaining 2 patients suffered ischaemic pain but without recent infarction. Seventeen patients were studied within 24 hours, and all within 48 hours, of the onset of symptoms. Seven patients were in left ventricular failure and 2 were in a state of shock. One was drowsy as a side effect of an intravenous infusion of lignocaine (I.5 mg/min) required to control ventricular premature beats. The other I0 patients were free of complications apart from pain which was present in 8. One patient was being paced for a third degree heart block and one, already mentioned, had ventricular premature beats. The others were in sinus rhythm.
Methods
The patients were studied recumbent in bed before and after the administration of pentazocine 30 mg. The drug was injected into a previously set up intravenous infusion of dextrose-saline, and the patient was usually unaware that any medication had been given. Arterial blood samples were obtained from indwelling catheters, inserted by the Seldinger technique, in ii patients and by direct arterial puncture in 9. These 9 were little disturbed by arterial puncture. Samples were collected in heparinized glass syringes and analysed in duplicate, using standard Radiometer microelectrode equipment, for pH, P02, and Pco0. Samples from patients breathing oxygen were analysed within I0 minutes and those from patients breathing air within 6o minutes, the samples being kept meanwhile on ice. Duplicate readings were accepted if they agreed to within O-OI units ofpH, i mmHg of CO2, and I0 mmHg of 02 in the 0-I200 range or 2 mmHg in the OI25 range. The pH and PcO2 electrodes were calibrated according to the maker's instructions and the P02 electrode with saturated gases analysed by a Haldane apparatus.
Systemic arterial blood pressure was measured by direct intra-arterial recordings in 9 patients. Readings were begun when the patient was in a steady state as indicated by heart rate and blood pressure. Forty-five minutes after pentazocine had been given, the bed-head was abruptly raised (with prior zero correction) so that the patient made an angle of 30 degrees to the horizontal. Pulmonary artery pressures and central venous samples were obtained in 5 of these patients via the floating catheter technique described by Bradley (I964) .
The effect of pentazocine on the response to oxygen was separately studied in 6 patients. Readings were taken breathing air and again at least I5 minutes after the patient had breathed oxygen from nasal spectacles in 3 cases and from a mask and reservoir in the other 3. The readings were then repeated 30 minutes after pentazocine had been given.
Base excess and per cent oxygen saturation were calculated from P02, pH, Pco2, and haemoglobin levels, while paired t tests have been used to assess statistical significances.
Results-pentazocine Though this study was not designed to assess the analgesic effectiveness of pentazocine, it was noted that a dose of 30 mg relieved the pain of myocardial infarction when it was moderate or slight but only partially when it was severe. Transient vertigo was the only harmful side effect while a beneficial sedative action was seen in 5 patients.
Arterial blood gases and acid-base balance (room air) ( (3) pH and base-deficit or excess. There were significant falls in pH after pentazocine, but the total lack of change in base deficit or excess indicates that these pH changes were due solely to the rise of Paco2 described above.
Oxygen saturation-room air ( Heart rate and systemic and pulmonary arterial pressures (air) (Table 2) After pentazocine heart rate rose slightly in 4 patients, remained unchanged in i, and fell slightly in 3. When these patients were tilted head up the rate remained unchanged in 6 patients and rose slightly in 2.
Mean systemic arterial pressure tended to rise-rising in 6 patients, remaining unchanged in 2, and falling slightly in i at i0 minutes after the drug. By 30 minutes pressure remained raised in 4 patients and approximated control values in the remainder. None of these changes achieves significance. When patients were tilted pressures rose slightly in 3 patients, fell slightly in i, and were unchanged in the remainder. No patient became hypotensive.
Mean pulmonary artery pressures rose in 2 patients and fell in 3 after pentazocine. In general terms changes were small and not significant.
Heart rate and systemic arterial pressure (oxygen) (Table 2) Alterations in heart rate when changed from air to oxygen breathing were small and insignificant. They were not affected by pentazocine. However, arterial pressure rose in all 6 patients when changed from air to oxygen and this increase is significant (P < o-oi). After pentazocine pressure then fell in 4 patients and rose yet again in 2 (one of these being in left ventricular failure). These changes are not significant.
Discussion
The ideal analgesic for use after myocardial infarction would relieve pain and allay anxiety without any cardiorespiratory or other action whatever. No such drug exists. Commonly used strong analgesics are morphine, heroin, pethidine, and pentazocine. Various studies have been undertaken on these drugs in myocardial infarction, namely morphine (Thomas et Respiratory depression Goodman and Gilman (I970) suggest that equianalgesic doses of morphine (io mg), heroin (3 mg), and pethidine (ioo mg) depress respiration to a similar extent in normal man. The equianalgesic dose suggested for pentazocine is 30-50 mg and the equidepressant dose 20 mg.
The relevant doses used in these studies were heroin 5 mg, pethidine I00 mg, pentazocine 30 mg (this study) and 6o mg (Lal et Neither of these drugs had any consistent action upon heart rate after myocardial infarction and mean changes were small. Nevertheless, morphine is known to produce occasional profound and unpredictable bradycardia such as was observed and discussed by Thomas et al. (I965a) . These authors also encountered severe postural hypotension as a side effect of morphine -noting that such hypotension was usually accompanied by the bradycardia, but could precede it. Such postural hypotension is well known to occur after morphine but surprisingly not so after heroin -since both drugs decrease the capacity of the cardiovascular system to respond to the stress of gravitational shifts. Apart from postural hypotension both drugs produce a small but definite fall in systemic arterial pressure -maximal shortly after injection and approaching control values by thirty minutes. They are probably of com-6 parable magnitude for each drug.
Changes in pulmonary arterial pressure after morphine in myocardial infarction have not been recorded, while those after heroin were small and inconsistent. Changes in cardiac output after morphine in normal man are small and inconsistent (Goodman and Gilman, I970) and the findings after i5 mg intramuscularly in myocardial infarction (Grendahl and Hansteen, I969) (Goodman and Gilman, 1970) . Postural hypotension is not reported to be a side effect of pethidine in therapeutic dosage. Changes in pulmonary arterial pressure and cardiac output after the drug in myocardial infarction were small -output tending to fall and pressure to rise. Neither of these changes achieved significance.
C. Pentazocine
The cardiovascular actions of pentazocine are of considerable interest. All 4 studies of the drug indicate a rise in both heart rate and systemic arterial pressure after its use in myocardial infarction -though such rises in general only achieve significance after a 60 mg dose. This increase in systemic arterial pressure was assumed to be caused by changes in peripheral resistance. However, Levitsky et al. (197I) , in experiments on dogs, have shown the drug to have a positive inotropic effect (as shown by changes in left ventricular dp/dt) and that this effect is blocked by propranolol. These different findings provide a nice paradox. In an experimental situation the drug appears to have a beneficial effect upon the heart, while in a clinical situation the effects are potentially deleterious. However, unlike the findings of the experimental study -pentazocine provoked a significant rise in peripheral resistance after the 6o mg dose given after myocardial infarction. That an increase in peripheral resistance was not the sole factor operative in causing a rise in systemic pressure was shown by there also being a significant rise in systemic pressure 5 minutes after the 30 mg dose without change in peripheral resistance. General physiological principles associate a rise in peripheral resistance with a fall in heart rate which does not occur after the drug. Accordingly, in human myocardial infarction the rise of pressure is probably caused both by a rise in peripheral resistance and by a local fl-stimulating effect on the heart. However, excess catecholamine release is a known feature of myocardial infarction. The actual amount released correlates with the severity of the infarction (Rosenbaum and Doyle, I970). Accordingly, the more severe the infarction the greater the endogenous f stimulation of the heart and the less will myocardial fi receptors be responsive to exogenous stimulation. Any rise in peripheral resistance caused by pentazocine will cause simply an increased after-load, badly tolerated by a heart severely stressed by myocardial infarction -hence, a rise in left ventricular end-diastolic and pulmonary artery pressures. (Goodman and Gilman, I970) . All 3 drugs can additionally produce dizziness after intravenous injection and this is more common after pentazocine than after morphine or heroin. This dizziness is also a side effect of intravenous pethidine. Popular belief thinks pethidine to be less emetic than morphine. This is not supported by factindeed, Dundee et al. (I965) actually found nausea and vomiting to be more common than after morphine.
The incidence of nausea and vomiting after analgesia is undoubtedly dose related. Dundee et al. (I967) found its incidence to rise sharply when doses of io mg morphine or 5 mg heroin were exceeded. It also seems likely that the route of administration may be important, but information is scant. Rapid intravenous injection should certainly be avoided.
It is common practice to administer phenothiazines concurrently with the opiates in order to avoid vomiting and enhance sedation. Since the phenothiazines not only augment opiate induced respiratory depression but also greatly increase the risk of hypotension (Goodman and Gilman, I970) , this practice is not to be recommended.
Summarizing the intravenous actions of the four drugs, it seems that neither pethidine group.bmj.com on June 23, 2017 -Published by http://heart.bmj.com/ Downloaded from nor morphine are suitable for pain relief after myocardial infarction. The sedative action of pethidine is less and the incidence of complications -particularly cardiovascular -probably higher than with the other drugs. Morphine has a high incidence of emetic side effects and may cause profound and unpredictable hypotension. The choice therefore appears to lie between pentazocine and heroin. Pentazocine may be less emetic and has what appears to be an attractive side effect -the ability to raise systemic blood pressure. Unfortunately this rise in blood pressure after myocardial infarction is almost certainly due little to a positive inotropic action and largely to a rise in peripheral resistance. There are those who believe a rise in blood pressure to be entirely beneficial, stating that in severe myocardial ischaemia the coronary arteries are maximally dilated and therefore myocardial blood flow is entirely pressure dependent (Brachfeld and Gorlin, I960) . While this viewpoint has much to recommend it, it is absurd to raise the blood pressure further in a patient whose blood pressure is already adequate -the more particularly since oxygen, which should be given to all patients, has just this action (Thomas, Malmcrona, and Shillingford, 
